Back to search

Democritus University of Thrace (DUTH)

Ουδετερόφιλο και μεταβολικό-ενεργειακό περιβάλλον

Abstract

dc:description

Type 2 diabetes mellitus (T2D) is a metabolic disease that represents a significant health problem with increasing prevalence worldwide. T2D is characterized by chronic inflammation and insulin resistance, and has been associated with higher risk of infections and impaired wound healing, features that commonly lead to serious complications and high mortality.Neutrophil extracellular traps (NETs), a key defensive mechanism of neutrophils, are involved in various non-infectious diseases, including T2D, and their pathogenic role is defined mainly by their disease-related protein load. NETosis in T2D is impaired leading to the delayed release of short-lived and unstable NETs, an impairment that has been implicated in increased susceptibility to bacterial infections and wound healing incapability.LL-37 is an antimicrobial peptide with an important role in defense against bacterial infections, expressed by various cell types including neutrophils. Recently, our group demonstrated that the macrolide antibiotic clarithromycin induces the formation of LL-37-bearing NETs with potent antimicrobial activity. LL-37 has been associated with wound healing as well, given that it promotes re-epithelialization and vascularization.Considering the antimicrobial and wound healing properties of LL-37 as well as its presence on NETs under certain inflammatory conditions, we investigated whether LL-37 is present on diabetic NET structures. Using immunofluorescence, we found that both neutrophils isolated from treatment-naive T2D patients with impaired glycemic control and those isolated from well-controlled T2D patients with good glycemic control spontaneously release decorated with LL-37 NETs.As a result, we next investigated the antimicrobial activity of LL-37-bearing diabetic NET structures. The experimental procedure was performed using bacterial strain E. coli NCTC 9001, which were cultured in the presence or absence of in vitro generated T2D NETs. Although decorated with the potent antimicrobial peptide LL-37, diabetic NETs had no inhibitory effect on bacterial growth, irrespective of whether they derived from treatment-naive or well-controlled patient’s neutrophils.Based on the above finding, we examined whether clarithromycin could restore the in vitro antibacterial activity of diabetic NET structures. Thus, E. coli NCTC 9001 cultures were performed in the presence of NETs generated by T2D neutrophils upon in vitro stimulation with clarithromycin. Only clarithromycin-induced NETs from neutrophils of well-controlled patients were able to significantly reduce bacterial growth and their antibacterial properties were significantly abrogated when NET-bound LL-37 was neutralized with anti-LL-37 antibody. These findings suggest that clarithromycin restores the in vitro antibacterial properties of NET structures in normoglycemic T2D patients, in an LL-37-dependent manner.Clarithromycin did not further enhance the ability of diabetic neutrophils to release NETs spontaneously, as assessed by MPO-DNA complex ELISA, but it significantly increased the LL-37 levels on well-controlled T2D NETs, as assessed by immunoblotting and LL-37 ELISA. Thus, our experimental data propose that the improved in vitro antibacterial activity of clarithromycin induced well-controlled T2D NETs could be attributed to the increased externalization of LL-37 on these NETs.Taking into account the increasing evidence that LL-37 promotes wound healing, we investigated whether decorated with LL-37 T2D NETs are implicated in wound healing process, as well as the effect of clarithromycin. The experimental procedure was performed by incubating human skin fibroblasts (SFs) with in vitro generated T2D NETs, spontaneously and upon induction with clarithromycin, in order to study the effect on the activation of SFs and their differentiation into myofibroblasts. Clarithromycin-induced NETs from neutrophils of well-controlled patients had a significant inductive impact on the activation and differentiation of SFs, which was attributed to the increased levels of LL-37 on these NETs. This assumption was further supported by our final finding that diabetic NETs are not decorated with IL-17, a protein which also promotes fibrotic activity of fibroblasts when decorating NETs, neither clarithromycin induces its expression.Concluding, this study suggests that clarithromycin could add further advantage to well-controlled T2D patients, by both enhancing antibacterial activity of neutrophils and improving wound healing capacity of fibroblasts, through upregulation of LL-37 on NET structures.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Arampatzioglou, Athanasios
  • Αραμπατζιόγλου, Αθανάσιος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45956

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Arampatzioglou, Athanasios; Αραμπατζιόγλου, Αθανάσιος. Ουδετερόφιλο και μεταβολικό-ενεργειακό περιβάλλον. Democritus University of Thrace (DUTH), 2019. http://hdl.handle.net/10442/hedi/45956